Bontempi EJ., Cazzulo JJ. Digestion of human immunoglobulin G by the major cysteine proteinase (cruzipain) from Trypanosoma cruzi. FEMS Microbiologu Letters. 70,337-342, 1990 Bua JE, J Bontempi, AM Ruiz, EL Segura. Antígenos en Tripanosoma cruzi. Rev Arg Microbiol. 22:47-66, 1990

Cardoni RL, ME Rottenberg, EL Segura. Increased production of reactive oxygen species by cells from mice acutely infected withT. cruzi. Cell Inmunol. 128:11-21, 1990

Kaleab B, T Ottenhoff, P Converse, E Halapi, G Tadese, M Rottemberg, R Kiessling. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients. Eur J Inmunol, 20:2651-9,1990

Ouaissi MA, A Taibi, J Cornette, P Velge, R Marty, M Loyens, M Esteva, FS Rizvi, A Capron. Characterization of major surface and excretory-secretory inmunogens of Trypanosoma cruzi trypomastigotes and identification of potential protective antigen. Parasitol. 100:115-24, 1990

Perez AC, E Cura, E Subias, JC Lansetti, EL Segura. Long-term preservation of blood samples for diagnosis of Trypanosoma cruzi infection. Trop Med 41:75-6, 1990

Rottemberg ME, RJ Cardoni, EL Segura. Involvement of L374+, LYT2.2+ T cell subsets and non-T cells in the resistance of mice against Trypanosoma cruzi infection. Inter J Parasitol. 20(3):397-400, 1990

Rabinovich JE, C Wisnivesky-Colli, N Solarz, Gurtler. Probability of transmission of ChagasÕdisease by Triatoma infestans (Hemiptera: Reduviidae) in an endemic area of Santiago del Estero, Argentina. Bull World Health Organ. 68(6):737-46, 1990

Ruiz AM, M Esteva, E Subias, M Moreno, AR de Campanini, E Velazquez, EL Segura. Monoclonal antibodies against the flagellar fraction of epimastigote of T. cruzi. II Inmunoprotection against metacyclic trypomastigotes obtained by inmunization of mice with an affinity purified antigen. Mol Biochem Parasitol. 30:117-26, 1990

Segura EL. y Ruiz AM. Enfermedad de Chagas o Tripanosomiasis Americana. In Compendio de Parasitosis humanas producidas por protozoos. Enfermedad de Chagas, Leishmaniasis, Malaria y Toxoplasmosis. Ed. Carlomagno et. al. Instituto Nacional de Chagas Dr. MArio Fatala Chabén. Buenos Aires, Argentina, 1990

Auler F., Riarte A., Pattin M., Segura EL., Vazquez M. Chagas disease and kidney transplantation. Transplanting Proceedings 23(5) 2653, 1991

Bua JE, Bontempi J, M Lovin, A orn, D Velazco, M Moreno, P Levi-Yeyati, A Engstrom, EL Segura, AM Ruiz. Trypanosoma cruzi: cellular and antibody response against the parasite in mice inmunized with a 19-Amino acid synthetic peptide. Exp Parasitol. 72:54-62, 1991

Carlomagno MA, AR Riarte, EL Segura. Effects of renuttrition on caloric-deficient mice duringT. cruzi infection. Nutr Res. 11:1285-91, 1991

Fichera L, D Salomón, A Stoka. Structures properties and inmunological identity of vitelin isolated from triatominae species. Acta Physiol Pharmac Latinoam. 41(4):405-15,1991

Gurtler RE., Cécere MC., Rubel DN., Petersen RM., Schweigmann NJ., Lauricella MA., BUjas MA., Segura EL., Wisnivesky-Colli C. Chagas disease in north-west Argentina infected dogs as a risk factor for the domestic transmission of Trypanosoma cruzi. Trans. Roy. Soc. Trop. Med. Hyg. 85 741-745, 1991

Paulone I., Chuit R., Pérez AC., Canale D., Segura EL. The status of transmission of Trypanosoma cruzi in an endemic area of Argentine prior to control attempts, 1985. AM. Trop. Med. and Parasit. 85, 1991

Paulone I, El Segura. The status of transmission of Trypanosoma cruzi in an endemic area of Argentina prior to control attempts. Ann Trop Med Parasitol. 85(5):489-97,1991

Rodriguez JR, E Gros, AM Stoka. Synthesis and biological activity of juvenile hormone (JHA) for T. cruzi. Biorganic and medicinal Chemistry Letters, 1:12, 1991

Rottemberg ME, RL Cardoni, A Sinagra, A Riarte, I Rodriguez Nantes, M Lauricella, El Segura. Trypanosoma cruzi: T-cell-dependent mechanims of resistance during chronic infection. Exper Parasitol. 73:127-36, 1991

Rottemberg ME., de Titto E., Cardoni R., Segura EL. Respuesta inmune en la infección con T. cruzi. Rev. Arg. Microbiol. 23, 101-121,1991

Sanz OP, RL Cardoni, AM Celentano, MT Rimoldi, RE Sica, SM González Cappa. T. cruzi: induction of changes in the peripheral nervous system in differents strains of mice. Rev Argent Microbiolog. 23:30-4, 1991

Dasso MC, de Titto, EH. Electrophoretic analysis of T. cruzi proteins. An Asoc Quim Argent. 80(1-3):293-304,1992

de Titto EH., Segura EL. Is Chagas disease genetically regulated?. Human Immunol. V Ltin American Histocompatibility Workshop, pp. 100-110, 1992

de Titto E. y Laucella SA. Mimetismo Molecular y Patología en la Enfermedad de Chagas. Simposio Satélite, Córdoba, noviembre 1992, 101-105

Fichera LE, A Riarte. Embryology of Triatoma infestans (Klug) (Hemiptera, Reduviidae), a ChagasÕdisease vector. Rev Inst Med Trop S Paulo. 34:211-6, 1992

Forniciari G., Castagna M., Viacava P., Tognetti A., Esteva M., Segura EL. Bevilacqua, G Malattia di Chagas in una mummia peruviana Inca del Museo Nazionale di Antropologia ed Etnologia di Firenze. Archivio per 1 Antropologia e la Etnologia, 122:369-376, 1992

Gorelik G., Borda E., Postan M., Gonzalez Cappa S. T lymphosites from T.cruzi infected mice alter heart contractility:participation of arachidonic acid me abolites. J. Mol. Cardiol. 24:9-20, 1992

Porcel BM, J BÏa, M Esteva, E Bontempi, EL Segura, AM Ruiz. Obtención de una proteína recombinante inmunogénica en ratones BALB/c semejante al antígeno 1 de 43 KDa. presente en la superficie delT. cruzi. An Asoc Quim Argent. 80(1-3):271-83,1992

Segura EL., Ruiz AM. Trypanosoma cruzi. En Enfermedades Infecciosas y Microbiología Clínica. Ed Perea EJ, Edic. DOYMA, Madrid, Espa­a. Cap. 82,989-994, 1992

Slimovich R, C Rivas, EV Velázquez, AM Ruiz, EL Segura. Anticuerpos monoclonales anti Leishmania brasiliensis: desarrollo de un ensayo de inmunocompetición y análisis de sueros con reactividad cruzada entre Lehismania yT. cruzi. An Asoc Quim Argent. 80(1-3):285-92,1992

Tarleton RL., Koller BH., Latour A., Postan M. Susceptibility of beta-2-microblobulin deficient (MHC class I-negativ, CD8-) mice to T.cruzi infection. Nature 356-338-340, 1992

Zwirner NW., Malchioldi EL., Chiaramonte MG., Margni RA., Esteva M., Fossati CA. Caracterización de un antígeno de Trypanosoma cruzi purificado con anticuerpos monoclonales. Utilidad diagnóstica y análisis de su immunogenicidad. Immunología, 4:120-127, 1992

Bontempi EJ, J BÏa, L Aslund, B Porcel, J Henriksson, A Din, EL Segura, U Pettersson, AM Ruiz. Complete sequence and genome organization of a Trypanosoma cruzi gene that codes for a 46 KDa protein homologues to a rat and human tyrosine aminotransferase.Mol. Biochem. Parasitol. (59):253-262,1993

Chuit R., Paulone I., Wisnivesky-Colli C., Bo R., Pérez AC., Sosa Estani S., Segura EL. Results of a first step toward community-based survillance of transmission of Chagas disease with appropiate technology in rural areas. AM. J. Trop. Med. Hyg. 46(4) 444-450, 1993

Laucella SA. y de Titto E. Aspectos inmunológicos de la Enfermedad de Chagas crónica. Medicina (BS AS). 53: 50-51, 1993 Lauricella MA., Wisnivesky -Colli, C., Gurtler R., Pettersen R., Bujas M., Segura EL. Standarization of serological test for detecting anti-Trypanosoma cruzi in dogs. Mem. Inst. Oswaldo Cruz 88(3) 413-417, 1993

Ruiz AM., Bua J. y Segura EL., Antígenos del Trypanosoma cruzi: Perspectivas futuras. In Enfermedad de Chagas. Ed Storino R, Mieli J, Edic. DOYMA, Madrid, Espa­a. Cap. 32, 1993

Segura EL., Esquivel ML., Sosa Estani S., Chuit R. Control de la Enfermedad de Chagas en Argentina. PAMI Científico 8:11-26, 1993

Sinagra A., Riarte A., Lauricella MA., Segura EL. Reactivation of experimental chronic T.cruzi infection following immunosuppresive treatment by Cyclosporina and betametasona. Transplantation (brief communication) 55(6), 1993

Sosa Estani S., Velazquez E., Segura EL., Yampotis C., Yelamos M., ALbornoz P., Medina L. Quimioterapia en ni­os en fase indeterminada reciente de enfermedad de Chagas. Medicina Buenos Aires, 53 Supl. 1 PR 23: 20-21, 1993

Bontempi EJ., Porcel BM., Henriksson J., Carlsson L., Rydaker M., Segura EL., Ruiz AM., Pettersson U., Genes for histone H3 in Trypanosoma cruzi. Mol. Biochem. Parasitol. 66,147-151, 1994

Cardoni RL. Alteraciones de la respuesta inmune en la infección aguda con T. cruzi. Revisión. En "Enfermedad de Chagas". Ed. J Miler y R Storino; Mosby/Doyma, 87-102, 1994

Carlomagno M., Hansen D., Villacrés-Erikson M., Akerblom L., Hellman U., Segura EL., Morein B.. Inmunosuppression by monoclonal antibodies prepared with T.cruzi iscoms. Anales del VIII Congreso de Parasitología. Turquia, 1994

de Titto E. Bases genéticas de la Enfermedad de Chagas. En: Enfermedad de Chagas (Storino R., Milei Eds) Ed. DOYMAS Argentina, Buenos Aires, pp. 75-86, 1994

Esquivel ML. y Segura EL. Estimación del nÏmero de infectados chagásicos en Argentina, Medicina (BsAs)54:(1) 91-2, 1994

Esquivel ML., Salomón D., Gómez A., Sosa Estani S., Luna AC., Segura EL. Desarrollo de la Segunda etapa de Alternativas de Vigilancia de la Enfermedad de Chagas:Participación Comunitaria Ò María IIÓ Revista SOc. Bras. Med. Trop. 27 (suple. 1 ) 79, 1994

Postan M., Correa R., Ferrans V. and Tarleton RL. In vitro culture of cardiac mast cells from mice experimentally infected with T cruzi. Internat. Arch. Allergy Immunol. 105: 251-257, 1994.

Salomón D. Presencia de Lutzomyia punctigeniculata (Floch et Abonnec) (Diptera:Psychodidae) en la RepÏblica Argentina. Rev. Soc. Entomológica Argentina 53 (1-4), 1994

Tarleton RL., SUN J., Zhang L., Postan M. Depletion of T-cell subpopulation results in exacerbation of myocarditis and parasitism in experimental Chagas disease. Infect. Immun. 62:1820-1829, 1994

Viotti R., Virgiliano C., Armenti H., Segura EL., Treatment of chronic Chagas disease with benzmidazole: clinical and serologic evolution of patients with long-term follow-up. Am. J. Heart. 127 (1):151-161, 1994

Henriksson J, Porcel B, RydÎker M, Ruiz AM, Cazzulo JJ, Frasch AC and Pettersson U. Trypanosoma cruzi genome project: Chromosome-specific markers reveal conserved linkage groups in spite of extensive chromosomal size variation. Mol. Biochem. Parasitol., 1995

Jazin EE., Bontempi E., Sanchez DO., Aslund L., Henriksson J., Frasch ASCC., Pettersson U. Trypanosoma cruzi exoantigen is a member of a 160 kDa gene family. Parasitology. 110: 61-69, 1995

Montemartini M, Bua J, Bontempi E, Zelada C, Ruiz AM, Santome J, Cazzulo JJ and Nowickii C. A recombinant Tyrosine aminotransferase from Trypanosoma cruzi has both, Tyrosine Aminotransferase and Alanine Aminotransferase activities. FEMS Microbiol letters, 1995

Paveto C., Pereira C., Espinoza J., Montagna A., Farver M., Esteva. M., Flawiá M. and Torres H. The nitric oxide transduction parthway in Trypanosoma cruzi. The Journal of Biological Chemistry, 270 (8): 16576-9, 1995

Riarte A., Sinagra A., Lauricella MA., Bolomo N., Moreno M., Cossio P. and Segura EL. Chronic Experimental Infection by Trypanosoma cruzi in Cebus apella monkeys. Memorias Do Instituto Oswaldo Cruz. 90: 1-4, 1995

Rottemberg M., Riarte AR., Sporrong L., Altech J., Petray P., Ruiz AM., Wigzell H. and Orn A. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8. Inmunology Letters. 45: 53-60, 1995

Schavartzapel A., Fichera L., Esteva M., Rodríguez JB. and Gros EG. Helvetica Chimica Acta. 78, 1995

Carlomagno, M., Leer,G., Esteva,M., Hansen,D. and Segura, E.L. (1996) Role of Protein Deficiency on the Course of Trypanosoma cruzi Infection and on the Degree of Protection Conferred by a Flagellar Fraction. J. Nut. Immunol. 4:37-45.

Hansen,D.S., Villacrés-Eriksson,M., Åkerblom,L., Hellman,U., Segura,E.L, Carlomagno,M. and Morein,B. (1996) An Immunoaffinity purified Trypanosoma cruzi antigen suppresses antigen specific and mitogen- mediated cellular proliferation. Scan. J. Immunol. 46:.

Hansen,D.S., Allievi,G., Segura,E.L, Carlomagno,M., Morein,B. and Villacrés-Eriksson, M. (1996) The flagellar fraction of Trypanosoma cruzi depleted of an immunosuppresive antigen enhances protection to infection and elicits spontaneous T cell responses. Parasite Immunol. 18: 607-615.

Carlomagno MA, Hansen D, Villacres-Eriokson M, Åkerblom L., Hellman U., Segura EL and Morein B. (1996). Immune suppression by T. cruzi antigens identified by monoclonal antibodies prepared with T. cruzi iscoms. In New Dimensions in Parasitology. Acta Parasitológica Técnica. Chapter 8, pp 63-69.

Carlomagno,M., Hansen,D., Åkerblom,L., Esteva,M., Villacrés-Eriksson,M., Segura,E.L. and Morein,B. Incorporation of Flagellar Fraction of Trypanosoma cruzi into ISCOMS: Th1 and Th2 Interleukin levels and protective activity. (submitted).

Antúnez MI, Feinstein R, Cardoni RL and Grönvik K-O. (1997) T. cruzi. T cell populations in the Peyer's patches of BALB/c infected mice. Exp. Parasitology: 87: 58-64.

Antúnez MI, Cardoni RL. (1997). Superantígenos: una particular interacción entre microrganismos y el sistema inmune. Medicina (Buenos Aires) . 57: 608-616.

Laucella S, Salcedo R, Castaños Velez E, Riarte A, De Titto E, Patarroyo M, Orn A & Rottenberg M. (1996). Increased expression and secretion of ICAM-1 during experimental infection with Trypanosoma cruzi. Parasite Immunology 18: 227-139.

Laucella S.A., ME Rottenberg and E.H. de Titto. (1996) Papel de las citoquinas en la resistencia y patología durante la infección con Trypanosoma cruzi. Revista Argentina de Microbiología 28: 99-109.

Laucella S.A., E.H. de Titto and E.L. Segura. (1996) Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by natural antibodies: prognosis value in Chagas´disease. Acta Tropica. 62:151-162.

Laucella S.A.., E.H. de Titto, E.L. Segura, A. Orn and M.E. Rottenberg. (1996) Soluble cell adhesion molecules in human ChagasÕ disease: Association with disease severety and stage of infection. Am. J. Trop. Med. Hyg. 55: 629-634.

Porcel B., Bontempi E., Henriksson J., Rydaker M., Aslund L., Segura E.L., Pettersson U., Ruiz A.M. (1996). Trypanosoma rangeli and Trypanosoma cruzi: Molecular Characterization of Genes Encoding putative Calcium-Binding Proteins, Highly Conserved in Trypanosomatides. Exp.Parasitol. 84: 387-399

Laucella S., Velazquez E., Dasso M., De Titto E. (1996). Trypanosoma cruzi and mammalian heart cross-reactive antigens. Acta Tropica 61: 223-238

Cardoni R., Antunez M., Orn A., Gronvik K.O. (1996). T Cell Receptor Vb Repertoire in the Thymus and Spleen of Mice Infected with Trypanosoma cruzi. Cellular Immunology 169: 238-245

Silber A., Búa J., Porcel B., Segura E.L., Ruiz A.M. (1997). Trypanosoma cruzi: Specific Detection of Parasites by PCR in Infected Human and Vectors Using a Set of Primers (BP1/BP2) Targeted to a Nuclear DNA Sequence. Exp.Parasitol. 85: 225-232

Cardoni R. (1997). La respuesta inflamatoria en la infección aguda con Trypanosoma cruzi. Medicina (BsAs.) 57: 227-234

Sinagra A., Riarte A., Luna C., Campanini A., Segura E.L. (1997). Leishmania (Viannia Braziliensis): Biological Behavior of Isolates from Argentina Patients, in golden hamsters. Am.J. Trop. Med. Hyg. 57(2): 115-118

Zingales B., Rondinelli E., Degrave W., Da Silveira J., Levin M., Le Paslier D., Modabber F., Dobrokhotov B., Swindle J., Kelly J., Aslund L., Hoheisel J.D., Ruiz A., Cazzulo J.J., Pettersson U. and Frasch A.C. (1997). The Trypanosoma cruzi genome initiative. Parasitology Today Vo.13 (1): 16-22

Cardoni R., Antunez M., Morales C., Rodriguez Nantes I. (1997). Release of reactive oxygen species by Phagocytic cells in response to live parasites in mice infected with Trypanosoma cruzi. Am.J. Trop. Med. Hyg. 56(2): 329-334.

Sosa Estani S., Segura E.L., Ruiz A.M., Velázquez E., Porcel B.M., Yampotis C. (in press). Efficacy of chemotherapy with Benznidazole in children in indeterminate phase of Chagas disease. Am. J. Trop. Med. Hyg.

Dictar M., Sinagra A., Verón M.T., Luna C., Dengra C., De Rissio A., Bayo R., Ceraso D., Segura E., Koziner B., Riarte A. (1998). Recipients and donors of bone marrow transplants affected by Chagas disease: management and preemptive therapy of parasitemia. Bone Marrow Transplantation. 21: 391-393.

Carriazo SC, Sembaj A, Aguerri AM, Requena JM, Alonso C, Bua J, Ruiz AM, Segura EL and Barral JM (1998) Polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients. Diag. Microbiology and Inf. Disease. 30 (3): 183-186.

Franke de Cazzulo BM, Bernacchi A, Esteva MI, Ruiz AM, Castro JA and Cazzulo JJ. (in press). Trypanocidal effect of B-diethylaminoethyl-diphenylpropyl-acetate hydrochloride (SKF525A; Proadifen) on different developmental forms of Trypanosoma cruzi. Medicina (Bs.As.)

Tarleton RL, Grusby MJ, Postan M & Glimsher LH. (1996) T. cruzi infection in MHC deficient mice: further evidence for the role of both class I and class II restricted T cells in immune resistance and disease. International lmmunology 8:13-22.

Tarleton RL, Nunez M, Zhang L, Heighs M, Postan M. (1996) Cytotoxic T cells as potential vaccine candidates for T. cruzi infection. En: New Dimensions in Parasitology. Ed. Ali Ozcel, Ege University Publishing Office, Bornova, Turkey pp. 71-78, 1996

Garg N, Postan M, Mensa-Wilmot K, Tarleton RL. (1997) Glycosylphosphatidylinositols are required for the development of T. cruzi amastigotes. lnfection lmmunity 65:4055-4060.

Imaz, M.S., Esteva, M., Velázquez, E., Ruiz, A.M., Segura, E.L., Marcipar, A. 1997. Inhibition of trypomastigotes infectivity by a monoclonal antibody directed to a glycoconjugated fraction of epimastigotes of Trypanosoma cruzi. Rev. Latinoam. Microbiol

Pzsenny V, Pereda G, Bontempi E, Angel S, Matrajt M, Guarnera E, Garberi JC. (1997). Actividad de anhidrasa carbónica en Toxoplasma gondii . Medicina (Buenos Aires), Vol. 57, Supl.3, 74.

Martín V, Echeverría P, Santillán G, Céspedes G, Matrajt M, Pzsenny V, Garberi JC, Guarnera E, Angel S. (1997). Antigenicidad de la proteína Rop 2 de Toxoplasma gondii expresada en Escherichia coli. Medicina (Buenos Aires), Vol. 57, Supl.3, 74.

Matrajt M, Angel S, Pzsenny V, Guarnera E, Garberi JC. (1997). Dos familias de DNA repetitivo se encuentran estrechamente ligadasa en el genoma deToxoplasma gondii . Medicina (Buenos Aires), Vol. 57, Supl.3, 74-75.

Castañera MB, Lauricella M, Chuit R, Gürtler RE. Evaluación del rol de centinela de la transmisión de T.cruzi de una población canina rural. (1997). Medicina (Buenos Aires), Vol. 57, Supl.3, 49.

Lauricella AM, Castañera MB, Lauricella MA, Gürtler RE. Evaluación clínico-sanitaria de perros mestizos de un área endémica para enfermedad de Chagas. Medicina (Buenos Aires), Vol. 57, Supl.3, 49.

 Arnaiz, M.R. y Postan, M.  Myocardial cell proliferation in T. cruzi infection.  Archives D' Anatomie et de Cytologie Pathologiques.  Clin. & Exp.  Pathology. 1998. p.496.

Franke de Cazzulo, B.M.; Bernacchi, A.; Esteva, M.; Ruiz, A.M.; Castro, J.A.; and Cazzulo, J.J.  Trypanocidal effect of -diethylaminoethyl-diphenylpropylacetate hydrochloride (SKF 52SA; Proadifen) on different developmental foms of Trypanosoma cruzi.  Medicina (Buenos Aires) 58: 415 - 418. 1998.

 M Dictar, A Sinagra, MT Verón, C Luna, C Dengra, A De Rissio, R Bayo, D Ceraso, E Segura, B Koziner, A Riarte.  Recipients and donors of bone marrow transpiants suffering from Chagas disease: management and preemptive therapy of parasitemia.  Bone Marrow Transpiantation 21: 391-393, 1998

 A Riarte, C Luna, R Sabatiello, A Sinagra, R Schíavelli , A De Rissio, E Maiolo, MM Garcia, N Jacob, M Pattin, M Lauricella, EL Segura & M Vázquez.  Chagas disease in patients with kídney transpiants: a seven years experience, 1989-1996.  Aceptado para publicar.  Clin & lnf Dis 1998.

 J Aitciass, A Sinagra, G Jaimovich, C Salgueira, V Milovic, A Requejo, L Feidman, C Luna, A De Rissio, A Riarte.  Early detection of reactivation of crhonic Chagas' disease foiiowing bone marrow transpiantation and preemptive therapy with benznidazol.  Transpl Infect Dis.  Aceptado para publicar. 1998

 Martin, M, Arcavi, M, Santillan G, Amendoeira MR, de Souza Neves E, Griemberg G, Guarnera E, Garberi JC and Angel S.. (1998).  Detection of human toxopiasma-specific immunogiobulins A, M and G with a recombinat Toxoplasma gondii roP2 protein Clinical and Diagnostic Laboratory lmmunology.  Sept: 627-631